Wakamoto Pharmaceutical Co., Ltd.'s total assets for Q3 2023 were ¥15.25B, a decrease of -3.52% from the previous quarter. JP:4512 total liabilities were ¥3.55B for the fiscal quarter, a -5.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.